مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Absolute Lymphocyte Count on Day 30 Is a Surrogate for Robust Hematopoietic Recovery and Strongly Predicts Outcome after T Cell-Depleted Allogeneic Stem Cell Transplantation
Keywords: AML; ALL; CML; Day 30 lymphocyte count; Allogeneic stem cell transplantation
Role of c-kit/SCF in cause and treatment of gastrointestinal stromal tumors (GIST)
Keywords: aa; amino acid; ATP; adenosine triphosphate; BMMC; bone marrow-derived mast cells; CML; chronic myelogenous leukemia; CSF; colony stimulating factor; EGF; epidermal growth factor; GIST; gastrointestinal stromal tumor; Grb2; growth factor receptor bound pr
Epigenetic regulation of PRAME gene in chronic myeloid leukemia
Keywords: PRAME; Hypomethylation; CML
The effect of total-ABL, GUS and B2M control genes on BCR-ABL monitoring by real-time RT-PCR
Keywords: CML; BCR-ABL monitoring; Real-time RT-PCR; Control genes; Disease status; Disease prognosis;
Accumulation of γ-globin mRNA and induction of irreversible erythroid differentiation after treatment of CML cell line K562 with new doxorubicin derivatives
Keywords: ACLA; aclarubicin; CML; chronic myelogenous leukemia; DRB; daunorubicin; DOX; doxorubicin; EDOX; epidoxorubicin; DOXM; morpholine derivative of doxorubicin; EDOXM; morpholine derivative of epidoxorubicin; DOXH; hexamethyleneimine derivative of doxorubicin
Roots of imatinib resistance: A question of self-renewal?
Keywords: Imatinib resistance; CML; Ph+ ALL; BCR-ABL; Self-renewal; BCR-ABL independent drug resistance
New insights into the pathobiology and treatment of chronic myelogenous leukemia
Keywords: CML; BCR-ABL; Pathology; Therapy; Imatinib; Staging
N-Benzyladriamycin-14-valerate (AD 198) cytotoxicty circumvents Bcr-Abl anti-apoptotic signaling in human leukemia cells and also potentiates imatinib cytotoxicity
Keywords: AD 198; PKC; Imatinib; Bcr-Abl kinase; CML
Nonreceptor Tyrosine Kinases in Prostate
Keywords: Nonreceptor tyrosine kinase; prostate cancer; Src; FAK; ETK; Abl; v-Abl Abelson murine leukemia viral oncogene homolog; At; androgenindependent; Aid; v-akt murine thymoma viral oncogene homolog 1; AR; androgen receptor; ARG; Abelson-related gene; Bcr; bre
Expression analysis of PCNA gene in chronic myelogenous leukemia-Combined application of siRNA silencing and expression arrays
Keywords: Cell cycle; CML; Expression arrays; Nucleofection; PCNA; Proliferation; siRNA;
Optimal control of treatment in a mathematical model of chronic myelogenous leukemia
Keywords: Optimal control; Mathematical model; CML; Leukemia; Drug therapy
Risk assessment in haemotopoietic stem cell transplantation: Disease and disease stage
Keywords: allo-SCT; prognostic factors; CML; CLL; AML; ALL; myeloma; lymphoma
HOXA9 gene expression in the chronic myeloid leukemia progression
Keywords: HOXA9; CML; Gene expression; Chronic phase; Accelerated phase; RT-PCR
Expression of the cell cycle regulators p14ARF and p16INK4a in chronic myeloid leukemia
Keywords: p14ARF; p16INK4a; CML; Q-RT-PCR; Gene expression
BNP as a marker of the heart failure in the treatment of imatinib mesylate
Keywords: BNP; Heart failure; Imatinib; GIST; CML;
RNA interference targeting of Bcr-Abl increases chronic myeloid leukemia cell killing by 17-allylamino-17-demethoxygeldanamycin
Keywords: CML; 17-AAG; RNAi; siRNA; Hsp90
Essential Thrombocythemia Beyond the First Decade: Life Expectancy, Long-term Complication Rates, and Prognostic Factors
Keywords: AML; acute myelogenous leukemia; CI; confidence interval; CML; chronic myeloid leukemia; ET; essential thrombocythemia; MDS; myelodysplastic syndrome; MMM; myelofibrosis with myeloid metaplasia; MPD; myeloproliferative disorder; PCR; polymerase chain reac
Exploring the Human Genome in Cancer with Genomic Approaches
Keywords: ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; CML; chronic myeloid leukemia; ER; estrogen receptor;
Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in Creutzfeldt–Jakob disease
Keywords: Prion; Creutzfeldt–Jakob disease; Oxidative stress; CEL; CML; AGE; RAGE; 4-HNE; MDAL; NOS; Nitrotyrosine; Superoxide dismutase
Peritransplantation Vaccination with Chaperone-Rich Cell Lysate Induces Antileukemia Immunity
Keywords: Chaperone/heat shock proteins; BMT; CML
Testing the safety of clinical-grade mature autologous myeloid DC in a phase I clinical immunotherapy trial of CML
Keywords: CML; DC; immunotherapy; T cells
Cytotoxic and apoptogenic effect of tea (Camellia sinensis var. assamica) root extract (TRE) and two of its steroidal saponins TS1 and TS2 on human leukemic cell lines K562 and U937 and on cells of CML and ALL patients
Keywords: TRE; tea root extract; TS; triterpenoid saponin; Ara-C; cytarabine; FCS; fetal calf serum; CML; chronic myelogenous leukemia; ALL; acute lymphoblastic leukemia; Annexin FITC; fluorescein isothiocyanate; MTT; 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetra
Disfunción endotelial
Keywords: Endotelio; Cardiovascular; Aterosclerosis; Ãxido nÃtrico; Endothelium; Cardiovascular disease; Atherosclerosis; Nitric oxide; ADMA; dimetilarginina asimétrica; ADP; adenosÃn difosfato; bFGF; factor de crecimiento de fibroblastos básico; CAM; molécul
Functional integrity in vitro of hematopoietic progenitor cells from patients with chronic myeloid leukemia that have achieved hematological remission after different therapeutic procedures
Keywords: CD34+ cells; CML; In vitro; IFN; IMATINIB; Marrow transplant; Proliferation
Atypical Myeloproliferative Disorders: Diagnosis and Management
Keywords: AML; acute myeloid leukemia; ASCT; allogeneic stem cell transplantation; CEL; chronic eosinophilic leukemia; CMD; chronic myeloid disorders; CML; chronic myeloid leukemia; CMML; chronic myelomonocytic leukemia; CNL; chronic neutrophilic leukemia; EMS; 8p1
Overcoming the inadequacy of single-criterion approaches to Life Cycle Assessment
Keywords: LCA; Impact assessment; Multicriteria; MFA; Emergy; CML
Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia: When Should It Be Used?
Keywords: ara-C; cytarabine; AP; accelerated phase; BC; blast crisis; CCR; complete cytogenetic response; CML; chronic myelogenous leukemia; GVHD; graft-vs-host disease; IRIS; International Randomised Study of Interferon versus STI571; MCR; major cytogenetic respon
Chronic Myeloid Leukemia: Diagnosis and Treatment
Keywords: ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; AP; accelerated phase; ATP; adenosine triphosphate; BP; blast phase; CCGR; complete cytogenetic response; CHR; complete hematologic response; CML; chronic myeloid leukemia; CP; chronic phase;
The Myelodysplastic Syndromes: Diagnosis and Treatment
Keywords: AA; aplastic anemia; ALG; antilymphocyte globulin; AML; acute myelogenous leukemia; APL; acute promyelocytic leukemia; ATG; antithymocyte globulin; ATRA; all-trans-retinoic acid; CALGB; Cancer and Leukemia Group B; CML; chronic myelogenous leukemia; CMML;
NUP98-LEDGF fusion and t(9;11) in transformed chronic myeloid leukemia
Keywords: CML; Blast crisis; NUP98; LEDGF;
Identification of leukemia-associated antigens in chronic myeloid leukemia by proteomic analysis
Keywords: CML; chronic myeloid leukemia; LAA, leukemia-associated antigen; 2-D; two dimensional; PVDF; polyvinylidene fluoride; MALDI-TOF; matrix-assisted desorption ionization-time-of-flight; SEREX; serological analysis of recombinant cDNA expression libraries; Ch
Elderly patients with Ph+ chronic myelogenous leukemia (CML): results of imatinib mesylate treatment
Keywords: CML; Imatinib; Elderly;
Ph-Chromosome-positive chronic myeloid leukemia with associated bone marrow mastocytosis
Keywords: SM; systemic mastocytosis; CML; chronic myeloid leukemia; AHNMD; associated clonal hematologic non-mast cell lineage disease; Mastocytosis; c-kit Mutation; CML; BCR/ABL;
The anti-leukemic efficacy of the third generation bisphosphonate ONO5920/YM529
Keywords: YM529; ONO5920/YM529; BP; bisphosphonate; P-gp; P-glycoprotein; DNR; daunorubicin; PAM; pamidronate; ZOL; zoledronic acid; Ph+; philadelphia chromosome positive; Ara-C; cytarabine; MDR; multidrug-resistant; FCS; fetal calf serum; CML; chronic myelogeneous
Immunohistochemical characterization of cutaneous drug eruptions by STI571
Keywords: Drug eruption; STI571; IL-18; IL-1β; ICAM-1; CML;
Exploiting structural principles to design cyclin-dependent kinase inhibitors
Keywords: CDK; cyclin-dependent kinase; PKA; cAMP-dependent protein kinase; CMGC-I; CDK-like protein kinases; CML; Chronic myelogenous leukaemia; PfPK5; Plasmodium falciparum Protein Kinase 5; Cyclin-dependent kinase inhibitor; CDK; Drug design; Protein dynamic; Pr
Engineering 3-alkyltriazenes to block bcr-abl kinase: a novel strategy for the therapy of advanced bcr-abl expressing leukemias
Keywords: CML; Temozolomide; Imatinib; DNA damage;
Cytokinetics and mechanism of action of AKO4: a novel nitrogen mustard targeted to bcr-abl
Keywords: CML; Chlorambucil; Imatinib; Apoptosis; Double-strand breaks;
Complement-opsonized HIV: the free rider on its way to infection
Keywords: C; complement; CML; complement-mediated lysis; E; erythrocytes; FDC; follicular dendritic cells; HAM; HIV-associated molecule; Complement; HIV; Infection; Pathogenesis; Infectious synapse;
Protein methionine content and MDA-lysine adducts are inversely related to maximum life span in the heart of mammals
Keywords: AASA; aminoadipic semialdehyde; CEL; NÉ-(Carboxyethyl)lysine; CML; NÉ-(Carboxymethyl)lysine; GC/MS; gas chromatography/mass spectrometry; GSA; glutamic semialdehyde; MDAL; NÉ-(Malondialdehyde)lysine; MLSP; maximum life span; PI; peroxidizability index;
Emergence and prevention of resistance against small molecule inhibitors
Keywords: Cancer; Drug resistance; Small molecule inhibitors; CML; Gleevec; Imatinib; Somatic evolution; Mathematical models; Computational biology;
CD39-associated high ATPase activity contribute to the loss of P2X7-mediated calcium response in LCL cells
Keywords: ALL; acute lymphoblastic leukemia; AML; acute myelogenous leukemia; ATP; adenosine-5â²-triphosphate; BSA; bovine serum albumin; βγMeATP; β,γ-methylene ATP; BzATP; 2â²,3â²-O-(4-benzoylbenzoyl)-ATP; CML; chronic myelogenous leukemia; DEPC; diethylpyr
Blood Eosinophilia: A New Paradigm in Disease Classification, Diagnosis, and Treatment
Keywords: AEC; absolute eosinophil count; CEL; chronic eosinophilic leukemia; CML; chronic myeloid leukemia; CMML; chronic myelomonocytic leukemia; FGFR1; fibroblast growth factor receptor 1; FISH; fluorescence in situ hybridization; HES; hypereosinophilic syndrome
Betulinic acid induces apoptosis in human chronic myelogenous leukemia (CML) cell line K-562 without altering the levels of Bcr-Abl
Keywords: BA; CML; K-562; Cytotoxicity and apoptosis;
Nuclear proteasome activation and degradation of carboxymethylated histones in human keratinocytes following glyoxal treatment
Keywords: AGE products; advanced glycoxidation end products; CEL; NÉ-carboxyethyllysine; CML; NÉ-carboxymethyllysine; DMEM; Dulbecco's modified Eagle's medium; GOLD; glyoxal lysine dimers; MOLD; methylglyoxal lysine dimers; OPA; o-phthaldialdehyde; PARP; poly(ADP
Immunochemical crossreactivity of antibodies specific for “advanced glycation endproducts” with “advanced lipoxidation endproducts”
Keywords: AD; Alzheimer's disease; AGE; advanced glycation endproduct; ALE; advanced lipoxidation endproduct; BSA; bovine serum albumin; CEL; carboxy-ethyl lysine; CML; carboxy-methyl lysine; DOLD; desoxyglucosone lysine dimer; FDP-lysine; N-(3-formyl-3,4-dehydro
Novel regulatory roles for protein phosphatase-2A in the islet β cell
Keywords: Protein phosphatase-2A; Pancreatic islet; Insulin secretion; Ceramide; Apoptosis; Diabetes mellitus; ACC; acetyl CoA carboxylase; CAPP; ceramide-activated protein phosphatase; CML; carboxylmethylation; GAPP; glutamate- and magnesium-activated protein phos
The JAK2V617F Tyrosine Kinase Mutation in Myeloproliferative Disorders: Status Report and Immediate Implications for Disease Classification and Diagnosis
Keywords: AML; acute myeloid leukemia; ATP; adenosine triphosphate; CMD; chronic myeloid disorders; CML; chronic myeloid leukemia; CMML; chronic myelomonocytic leukemia; CNL; chronic neutrophilic leukemia; CPTK; cytoplasmic PTK; EEC; endogenous erythroid colony; Ep
Effects of anthracycline derivatives on human leukemia K562 cell growth and differentiation
Keywords: ACLA; aclarubicin; CML; chronic myelogenous leukemia; DOX; doxorubicin; DOXH; hexamethyleneimine derivative of doxorubicin; DOXM; morpholine derivative of doxorubicin; DRB; daunorubicin; DRBH; hexamethyleneimine derivative of daunorubicin; DRBM; morpholin